Retzius-sparing vs. standard robot-assisted radical prostatectomy for clinically localised prostate cancer: a comparative study.

Journal: Prostate cancer and prostatic diseases
Published Date: Nov 29, 2022

Abstract

BACKGROUND: Retzius-sparing robot-assisted radical prostatectomy (RARP) is not yet universally accepted due to still limited functional data and some concerns on oncological safety compared to the standard one. We assessed perioperative, pathological and early functional outcomes in patients with clinically localised prostate cancer treated with Retzius-sparing versus standard RARP.

Authors

  • Vincenzo Ficarra
  • Marta Rossanese
  • Manuel Gilante
    Gaetano Barresi Department of Human and Paediatric Pathology, Urologic Section, University of Messina, Messina, Italy.
  • Mauro Foti
    Gaetano Barresi Department of Human and Paediatric Pathology, Urologic Section, University of Messina, Messina, Italy.
  • Luciano Macchione
    Gaetano Barresi Department of Human and Paediatric Pathology, Urologic Section, University of Messina, Messina, Italy.
  • Giuseppe Mucciardi
    Department of Human and Pediatric Pathology "Gaetano Barresi", Urologic Section, University of Messina, Italy.
  • Maurizio Martini
    Gaetano Barresi Department of Human and Paediatric Pathology, Pathology Section, University of Messina, Messina, Italy.
  • Gianluca Giannarini

Keywords

External Resources

Popular Topics
Recent Journals